Key result
Circulating miRNAs showed poor discrimination for coronary stenosis indexes (AUC 0.539-0.644) and failed to improve the discrimination capacity of conventional cardiovascular risk factors.
Why the study?
The diagnostic performance of circulating microRNAs as biomarkers in patients with suspected stable coronary artery disease needed to be explored.
Does a panel of 10 circulating miRNAs improve the diagnostic discrimination of coronary stenosis in patients with suspected stable CAD compared to conventional risk factors?
Observational (n=237)
Does a panel of 10 circulating miRNAs improve the diagnostic discrimination of coronary stenosis in patients with suspected stable CAD compared to conventional risk factors?
Effect estimate: AUC 0.539-0.644
Circulating miRNAs do not add incremental diagnostic value over conventional cardiovascular risk factors for detecting coronary stenosis in suspected stable CAD, though they may help classify specific patient subgroups.
MiRNAs should not augment stenosis detection beyond risk factors in suspected stable CAD; leaves open subgroup-specific utility.
OBJECTIVES: To explore the diagnostic performance of circulating microRNAs (miRNAs) as biomarkers in patients with suspected stable coronary artery disease (CAD). METHODS: Plasma samples were collected from 237 consecutive patients referred for coronary computed tomography angiography (CCTA). Presence, extension and severity of coronary stenosis were evaluated using the indexes: presence of diameter stenosis ≥ 50%, segment involvement score (SIS), segment stenosis score (SSS) and 3-vessel plaque score. A panel of 10 miRNAs previously associated with CAD was analysed using RT-qPCR. Multivariate analyses were used to analyse the associations between biomarkers and indexes. Discrimination was evaluated using the area under the ROC curve (AUC). Decision trees were generated using chi-squared Automatic Interaction Detector (CHAID) prediction models. RESULTS: After comprehensive adjustment including cardiovascular risk factors, medication use, confounding factors and protein-based biomarkers (hs-TnT and hs-CRP), several circulating miRNAs were inversely associated with coronary atherosclerosis extension (SIS and 3-vessel plaque score) and severity (SSS). In the whole population, circulating miRNAs showed a poor discrimination value for all indexes (AUC = 0.539-0.644) and did not increase the discrimination capacity of a clinical model of coronary stenosis presence, extension and severity based on conventional cardiovascular risk factors. Conversely, the inclusion of circulating miRNAs in decision trees produces models that improve the classification of cases and controls in specific patient subgroups. CONCLUSIONS: This study identifies a group of circulating miRNAs that failed to improve the discrimination capacity of cardiovascular risk factors but that has the potential to define specific subpopulations of patients with suspected stable CAD.
No takes yet. Share an insight, caveat, or question.
Gonzalo‐Calvo et al. (2019) conducted an observational in suspected stable coronary artery disease (CAD) (n=237). Circulating microRNAs (miRNAs) vs. Conventional cardiovascular risk factors was evaluated on Discrimination of presence, extension, and severity of coronary stenosis (AUC 0.539-0.644). Circulating miRNAs showed poor discrimination for coronary stenosis indexes (AUC 0.539-0.644) and failed to improve the discrimination capacity of conventional cardiovascular risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: